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Abstract
Phytoestrogens can control high-fat diet-induced hypothalamic inflammation
that is associated with severe consequences, including obesity, type 2 diabetes,
cardiovascular and neurodegenerative diseases. However, the phytoestrogen
anti-neuroinflammatory action is poorly understood. In this study, we explored
the neuroprotection mediated by daidzein in hypothalamic neurons by using a
membrane-based model of obesity-related neuroinflammation. To test the
daidzein therapeutic potential a biohybrid membrane system, consisting of
hfHypo GnRH-neurons in culture on PLGA membranes, was set up. It served
as reliable in vitro tool capable to recapitulate the in vivo structure and func-
tion of GnRH hypothalamic tissue. Our findings highlighted the neuro-
protective role of daidzein, being able to counteract the palmitate induced
neuroinflammation. Daidzein protected hfHypo GnRH cells by down-
regulating cell death, proinflammatory processes, oxidative stress, and apopto-
sis. It also restored the proper cell morphology and functionality through a
mechanism which probably involves the activation of ERβ and GPR30 recep-
tors along with the expression of GnRH peptide and KISS1R.
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1 | INTRODUCTION
Recent interdisciplinary studies in neuroscience have
found a close relationship between overnutrition, espe-
cially high-fat diets, and inflammation in the brain, and
particularly in the hypothalamus. The neu-
roinflammation causes a progressive damage of the neu-
rons that control food intake and energy homeostasis,
thus, leading to obesity, diabetes, and cardiovascular
complications. Overnutrition-induced hypothalamic
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inflammation is also linked to neurodegenerative dis-
eases such as Alzheimer's disease, Parkinson's disease,
and stroke.1 Therefore, the investigation of potential anti-
inflammatory agents that protect the hypothalamus from
diet-induced inflammation represents an active area of
research in the biomedical field.
Accumulating evidence suggests that intracellular dis-
turbances and stresses including endoplasmic reticulum
(ER) stress, oxidative stress, and autophagic defects are
important mediators of hypothalamic inflammation. How-
ever, it is still needed to highlight the multiple mechanisms
implicated in the induction of obesity-related neu-
roinflammation. Studies have demonstrated that elevated
levels of saturated fatty acids (SFAs), such as the highly
prevalent palmitate (PA), induce a state of neu-
roinflammation, characterized by several metabolic and
molecular changes and severe damages in hypothalamic
neurons. The accumulation of PA and its metabolites in
the hypothalamus has been shown to increase the mRNA
expression of pro-inflammatory cytokines, chemokines,
and reactive oxygen species (ROS), and can result in apo-
ptotic cell death.2,3 Nevertheless, the effect of PA-associated
hypothalamic inflammation on the different population of
hypothalamic neurons is not fully understood.
The finding that estrogenic compounds provide
neuroprotection against neuroinflammation although
they have many adverse effects (e.g., increased risk of
uterine, breast and endometrial cancer, heart disease and
liver complications) raise the need to explore substitute
compounds that have estrogenic properties without toxic-
ities, as an alternative to estrogen replacement therapy.
Isoflavones are natural polyphenolic compounds,
which act as phytoestrogens that have a diphenolic struc-
ture similar to estrogen with extensive pharmacological
properties4; recently, their role as anti-obesity agents is
emerging. Daidzein, 40,7-dihydroxyisoflavone, a major
isoflavone from soybean, is one of the most studied and
potent phytoestrogens.5,6 It has several activities such as
antioxidant, anti-inflammatory, antitumor, and cardi-
oprotective properties.7–9 Previous studies have also
reported the neuroprotective actions of daidzein against
hypoxia in primary cortical neurons, excitotoxicity,
β-amyloid, stroke-like injury, and ER stress-mediated
neuronal degeneration,10–12 besides to axonal outgrowth
in neuronal cells. Daidzein regulates pro-inflammatory
gene expression by activating PPAR-α and -γ and
inhibiting the JNK pathway in adipocyte and macro-
phage co-cultures.13 Recent evidences show the neuro-
protective effect of daidzein in hypothalamic N42 cells
against palmitic acid induced oxidative stress and apopto-
sis mediated by the transcriptional coactivator peroxi-
some proliferator-activated receptor γ coactivator 1 alpha
(PGC1-alpha), which plays a role in oxidative defense.14
Despite these data, the exact mechanism of daidzein's
neuroprotective effect has yet to be fully elucidated, spe-
cifically, the anti-neuroinflammatory action of daidzein
in hypothalamic neurons is poorly understood and
require further investigation. Indeed, considering the
prominent role played by the fatty acids excess (palmitate
administration) in the neuroinflammation induction2,3
and the daidzein mediated wide protection spectrum,7–14
it is reasonable to seek and highlight its capacity to stop
and/or revers the inflammatory cascade.
To address this issue, the present work aims to eluci-
date the potential protective role of daidzein against
palmitate-induced impairment in hypothalamic neurons
that were cultured in a biohybrid membrane system in
order to create an in vitro model of obesity-related
neuroinflammation.
Previous works provided a proof of concept that semi-
permeable polymeric membranes are advanced biomate-
rials with a feature complexity, mimicking the native
extracellular matrix (ECM), and topographical, chemical,
and bio-functional cues that enable neuronal growth and
differentiation.15 Membranes, differently from other bio-
materials that have been used to support neuronal cells
cultures (e.g., electrospun, hydrogels, self-assembling pep-
tides, nanoparticles, polystyrene dishes) display highly
selective properties, which allow to create a fully con-
trolled microenvironment at molecular level. These sys-
tems provide compartmentalization of cells governing the
mass transfer of molecules to and from cells and offering
appropriate structural and physico-chemical surface stim-
uli at nano and micro-scale, which are important for suc-
cessfully supporting and guiding neuronal tissue repair
and regeneration.16–18 Membrane-based approaches have
been used for the realization of valuable in vitro brain tis-
sue models as investigational platforms for studying
molecular mechanisms in physiological and/or pathologi-
cal states including neurodegeneration,19 drug testing,20
and potential therapeutic strategy.21,22
However, there is still a gap regarding the develop-
ment of an in vitro human neural tissue model. In the
current study, we realized a novel highly selective mem-
brane system for the culture of human hypothalamic
neurons. We employed a primary culture of human fetal
hypothalamic gonadotropin-releasing hormone (GnRH)
neurons (hfHypo), previously isolated, and characterized,
as cellular model whose functions have shown to be
impaired by inflammation.23 GnRH neurons are central
regulators of the reproductive function and respond to
inflammatory changes, thereby representing a crucial
hypothalamic population implicated in the pathogenic
mechanisms linking obesity to reproductive disorders.24
As previously shown, hfHypo cell function is deeply affected
by metabolic syndrome/obesity-related neuroinflammatory
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cytokines, such as TNFα,23 therefore, they represent a
novel and valuable tool for investigating the direct effects
of metabolic inflammatory factors in the human hypo-
thalamus and to unravel the potential protective role of
molecules, such as daidzein.
GnRH cell lines and other kinds of non-human
immortalized cell lines have been used in some papers to
study the effects of leptin, insulin and palmitate in the
hypothalamus,25,26 but the use of human primary GnRH
neurons is limited. Moreover, there are no reports con-
cerning the effects of daidzein on palmitate-induced neu-
roinflammation in hypothalamic neurons.
Hence, for the first time, we explored the anti-
neuroinflammatory effects and mechanisms of action of
daidzein in hfHypo neurons treated with palmitate. In this
regard, we hypothesized that dadzein, thanks to its steroid
structure, might activate, and exert neuroprotective effects
in several settings that involve activation of estrogen
receptors, as well as in regulating specific markers of neu-
ronal differentiation and/or GnRH phenotype. We investi-
gated its efficacy in promoting cell survival, in attenuating
and/or suppressing palmitate-induced ROS production,
mitochondrial dysfunction and apoptosis, and in retaining
GnRH phenotype in vitro, in order to explore the possible
underlying molecular mechanism.
The overall application represents also a promising
resource to use membrane technology as preliminary
drug screening in vitro tool for identifying new therapies
to treat neurological disorders as well as for preclinical
screening alternatively to animal experimentation.
2 | MATERIALS AND METHODS
2.1 | Membrane system: Preparation and
characterization
Membranes of Poly(D,L-lactide-co-glycolide) (PLGA) were
prepared in flat configuration by phase inversion technique.
PLGA (7,5% wt/vol) (Resomer® RG 505, Mn 54.000–69.000,
Sigma-Aldrich, Italy) was dissolved in dichloromethane.
The polymeric solution was cast uniformly on the surface
of a glass plate by using a handle-casting knife (Elcometer,
gap set at 250 μm), dried at room temperature until com-
plete solvent evaporation, and washed with distilled water.
Then, the obtained PLGA membranes were characterized
in order to evaluate their morphological, physico-chemical
and mechanical properties that play an important role in
guiding neuronal behavior.
Morphological properties of the PLGA membranes were
characterized by scanning electron microscope (SEM). Sam-
ples of membrane surface and cross section were mounted
with double-faced conductive adhesive tape, and, after gold
coating, analyzed by SEM (ESEM FEG QUANTA 200, FEI
Company) in order to evaluate surface and cross section
structure, shape and sizes of the membrane pores.
The membrane thickness was measured with Carl
Mahr 40E digital micrometer. Membrane mean pore
diameter was determined using a Capillary Flow Por-
ometer (CFP 1500 AEXL, Porous Materials Inc., PMI).
The physico-chemical properties of PLGA membrane
ware characterized by water dynamic contact angle
(DCA) measurements at room temperature by using a
contact angle meter, CAM 200 (KSV Instruments, Ltd.).
Mechanical properties were evaluated by Zwick/Roell
Z2.5 tensile testing machine. Membrane samples were cut
into strips of 5 × 1 cm, mounted between two pneumatic
grips, and subjected to uniaxial tension until failure. Ulti-
mate tensile strength (UTS), Young modulus (Emod) and
Elongation at break parameter (ε) were determined by
analyzing five replicates of membrane sample.
2.2 | Cell culture and treatments
Hypothalamic GnRH neurons (hfHypo) were isolated
from the brain of 12-week-old human fetuses as previ-
ously described,23 and then cryopreserved. The use of
human fetal biopsies for research purposes was approved
by the National Ethics Committee and the local Ethics
Committee for investigation in Humans of the University
of Florence (Protocol Number: 678304) and was per-
formed with the informed consent signed by the donors.
In the present work, hfHypo at passages P12–13 were
seeded at a density of 16 × 103 cell/cm2 on PLGA mem-
branes in Coon's modified Ham's F12 medium
(Euroclone, Milan, Italy) supplemented with 10% fetal
bovine serum, and cultured under standard conditions
(37C, 5% CO2). Polystyrene culture dishes (PSCD) were
used as reference substrates. The previous work has
shown the maintenance of the phenotype of this cell pop-
ulation until the passage P23.23
To realize an in vitro model of obesity-related neu-
roinflammation, neuronal cells after 48 h of culture in
PLGA membrane system were exposed to sodium palmi-
tate (PA, Sigma-Aldrich) at different concentrations
(0–600 μM) for 24–48 h at 37C. Palmitate was dissolved in
water (50C) to have a stock solution of 10 mM concentra-
tion and diluted in culture medium. The possible toxic
effect of daidzein was evaluated by treating cells with differ-
ent concentrations of molecule ranging from 0.1 to 10 μM.
To investigate the neuroprotective effects of daidzein
(DZ, Santa Cruz Biotechnology) against palmitate-
induced toxicity, cells were treated with a mixture of
palmitate (300 μM) and daidzein (PA + DZ) at different
concentrations (0.1, 1, and 10 μM) for 24 h at 37C.
MORELLI ET AL. 95
Daidzein was dissolved in DMSO to have a 10 mM stock
solution and added to the culture medium at the indi-
cated concentrations. We used the nomenclature “Con-
trol” to indicate untreated cells without palmitate and
daidzein treatment. After 24 h under the different treat-
ments, cells were sacrificed for morphological studies,
and assessment of cell viability, neuronal behavior and
functional responses, and the neuronal cell medium
supernatant was collected and stored at −70C for further
analyses. All experiments were conducted in triplicate
with the average of five samples for treatment (Control,
Palmitate and PA + DZ).
2.3 | SEM analysis
The morphology of hfHypo-GnRH neurons was investi-
gated by SEM analysis. All treated and untreated samples
of neurons grown in PLGA membrane system were fixed
with 2.5% glutaraldehyde for 30 min, followed by post-
fixation in 1% osmium tetroxide and then dehydrated
using a growing series of ethanol dilutions (10%–100%)
and finally air-dried. Samples were examined at SEM and
representative images displaying neuronal structural fea-
tures were obtained.
2.4 | Immunostaining for laser scanning
confocal microscopy
The behavior of hfHypo cells was analyzed by Laser
Scanning Confocal Microscopy (LSCM, Fluoview FV300,
Olympus) after the immunostaining of neuronal markers
(β-Tub III and Neuronal nuclei, NeuN), GnRH pheno-
type markers (GnRH peptide and kisspeptin receptor,
KISS1R) and estrogenic receptors (ER β and G protein-
coupled receptor 30, GPR30). Neurons were fixed in 4%
(wt/vol) paraformaldehyde for 30 min, followed by
permeabilization and blocking with a solution containing
0.3% (vol/vol) Triton X-100 and 10% (vol/vol) FBS in PBS
for 1 h at 37C. Samples were then incubated overnight
at 4C with the following primary antibodies: anti-βTub
III (1:500, Covance), anti-NeuN (1:200, Millipore), anti-
GnRH (1:100, Abcam), anti-KISS1R (1:200, Santa Cruz
Biotechnology), anti-ERβ (1:200, Santa Cruz Biotechnol-
ogy) and anti-GPR30 (1:200, Abcam). Secondary anti-
bodies, Cy2TM-conjugated Affini Pure donkey anti-rabbit
IgG, Cy3TM-conjugated Affini Pure donkey anti-
mouseIgG and a Cy5TM-conjugated Affini Pure donkey
anti-goat IgG (1:500, Jackson ImmunoResearch Europe
Ltd.) were then added for 1 h at RT. Finally, cells were
counterstained with 200 ng/ml DAPI (Molecular Probes),
for nuclear localization.
2.5 | Measurement of cell viability
Cell viability was measured by 3-(3,4-dimethylthiazol-
2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay
(Sigma-Aldrich). After 24 h of treatments, the culture
medium was replaced with serum-free medium con-
taining 5 mg/ml of MTT and incubated for 2 h at 37C.
Then, lysis buffer (10% SDS, 0.6% acetic acid in DMSO,
pH 4.7) was added to dissolve formazan crystals, and the
absorbance was measured with a spectrophotometer at a
570 nm wavelength. Cell viability is reported as percent-
age relative to control (100%).
2.6 | Cytokine determination
Cytokine production was assessed by analyzing the con-
centration of specific interleukins: Interleukin-6 (IL-6)
and Interleukin-10 (IL-10), which were quantified by per-
forming enzyme-linked immunosorbent assay (ELISA) in
the supernatants of neuronal cultures.
Specific detection of IL-6 and IL-10 concentrations
were obtained by a quantitative sandwich enzyme immu-
noassay technique.
A specific IL-6 ELISA kit (AbFrontiers) was employed
for the quantitative detection of the IL-6 released by cells
in the culture media, by following the manufacturer's
protocol.
Monoclonal antibody specific to IL-10 (Thermo Scien-
tific) was pre-coated onto a 96-well plate. Standards and
cell culture supernatant were added to the wells with
biotin-conjugated monoclonal antibody specific for IL-10.
Therefore, all IL-10 was captured by the immobilized anti-
bodies. Following a wash to remove any unbound sub-
stances, horseradish peroxidase-streptavidin conjugate was
added to bind to the biotin on IL-10. Following another
wash, a substrate buffer containing Tetramethylbenzidine
(Thermo Scientific) was added to the wells. The reaction
was stopped with 8 N H2SO4. Absorbance was measured at
450 nm using a Multiskan Ex (Thermo Lab Systems) and
was proportional to the amount of IL-10.
2.7 | Cellular ROS detection assay
ROS generation in cells was measured using the probe
20,70-dichlorodihydrofluorescein diacetate (H2DCF-DA,
Sigma-Aldrich), as previously described.20 This molecule
in presence of ROS is deacetylated and oxidized becom-
ing the green fluorescent dichlorofluorescein (DCF).
Then an increase in DCF fluorescence intensity is propor-
tional to the ROS level. Neuronal cells (16 × 103 cell/cm2)
in the membrane system, after 24 h of treatment with
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palmitate and the different concentration of daidzein,
were loaded with 50 μM H2DCF-DA at 37C for 30 min.
Then cells were washed twice with Hank's salt solution
and the DCF fluorescence intensity was measured with
LSCM, using an argon laser. Quantitative analysis was
performed on confocal images of cells by using Fluoview
5.0 software (Olympus Corporation).
2.8 | Mitochondrial membrane potential
measurement
The mitochondrial membrane potential of neurons was
measured by using the fluorescent cyanine dye 5,50,6,60-
tetrachloro-1,10,3,30-tetraethylbenzimidazolcarbocyanine
iodide (JC-1) (Sigma-Aldrich). JC-1 probe shows
potential-dependent accumulation in mitochondria. An
emitted red fluorescence (aggregates) indicates healthy
mitochondria with normal potential, whereas the mito-
chondria with reduced potential emit green fluorescence
(monomers). Therefore, the ratio of red to green fluores-
cence of JC-1 represents the condition of mitochondrial
membrane potential. Cell cultures were incubated at
37C with JC-1 (5 μg/ml) for 20 min. The fluorescence
intensity of both monomers and J-aggregates were
detected by LSCM. JC-1 green fluorescence was visual-
ized with Ar laser and red fluorescence from JC-1 aggre-
gates was detected using He/Ne green laser. Then,
red/green fluorescence intensity was measured, and a
quantitative analysis was performed on confocal images
of cells by using Fluoview 5.0 software.
2.9 | Apoptosis assay
The apoptotic degree was evaluated by investigating the
expression of two apoptotic markers, caspase-3 and
phospho-JNK (p-JKN), which were detected by immuno-
staining with rabbit anti-caspase-3 antibody (1:250, BD)
and mouse anti-p-JNK (Thr183/Tyr 185) antibody (1:250,
Santa Cruz Biotechnology), respectively. Quantitative
analysis of apoptotic cells was performed by calculating
the percentage of positive cells for each marker
(caspase-3 positive nuclei and p-JNK positive nuclei) over
the total (DAPI-stained nuclei).
2.10 | Statistical analysis
Statistical significance of the experimental results was
assessed using ANOVA test followed by Bonferroni t-test.
The results were expressed as mean ± SEM from at least
three independent experiments in which five samples for
each treatment were assessed. A p value <0.05 was con-
sidered to be statistically significant.
3 | RESULTS
3.1 | PLGA membrane system sustains
the growth of hfHypo neurons
PLGA membrane underwent to a full characterization in
order to disclose their intrinsic properties that strongly
impact on hypothalamic cell behavior in reorganizing
themselves according to a proper structure. For a faithful
tissue-like assembly, the appropriate cell displacement must
be reproduced as a consequence of the correct interactions
between cells and with the surrounding environment.
Flat PLGA membranes were morphologically charac-
terized through SEM analysis revealing a homogenous
and smooth surface, with nanopores regularly distributed
over it (Figure S1).
Porometer measurements pointed out a mean pore
size distribution of 20 ± 2 nm (Table 1). Membrane phys-
ical chemical properties directly influence cell-material
interaction and therefore the overall tissue formation
process. To better predict and evaluate membrane perfor-
mance in terms of cell growth supporting ability,
dynamic contact angle measurements were carried out.
Surface characterization pointed out an advancing con-
tact angle of 81 ± 3 and a receding one with a value of
44 ± 4, evidencing a moderate wettability which is a
desirable condition for promoting an optimal interaction
at the cellular-material interface. When cells are cultured
in vitro they can sense material rigidity, exhibiting a
stiffness-dependent behavior on the basis of the mechani-
cal features that characterize their natural niche. Biome-
chanical stimuli arising by the substrate are responsible of
cell migration, polarization, and differentiation, rep-
resenting therefore an important membrane characteristic
TABLE 1 Poly(D,L-lactide-co-glycolide) (PLGA) membrane
properties
PLGA membrane
Thickness [μm] 9.3 ± 1
Mean pore diameter [nm] 20 ± 2
WCA [] θadv 81 ± 3
θrec 44 ± 4
E [N/mm2] 315 ± 17
ε [%] 11 ± 0.8
UTS [N/mm2] 7 ± 0.6
Note: Advancing θadv and receding θrec contact angle; Young's modulus E;
elongation at break ε; ultimate tensile strength UTS.
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that needs to be investigated. PLGA membrane exhibits a
moderate stiffness as demonstrated by the Young's modu-
lus value of 315 ± 17 N/mm2 (see Table 1) in comparison
with other materials utilized for neuronal cells that range
from few hundred Pa (e.g., hydrogels) to 1–2 GPa
(e.g., tissue culture polystyrene).
The PLGA membrane properties characterization was
followed by its assessment in sustaining neuronal growth
and differentiation. PSCD were used as reference sub-
strate. This preliminary biological investigation is funda-
mental to validate our membrane system as reliable
hypothalamic tissue model for daidzein neuroprotective
screening. To prove this, hfHypo-GnRH neurons were
cultured on PLGA membranes and on PSCD and under-
went to morphological observation and evaluation. SEM
analysis after 3 days of culture evidenced that cells
established a proper interaction at the membrane inter-
face, clearly visible by the high degree of adhesion and
considerable portion of membrane surface covered by the
cells (Figure 1A). On both kind of substrate, PLGA mem-
branes (Figures 1A–C) and PSCD (Figures 1D–F), cells
reached a structural maturation, acquiring a typical bipo-
lar shape, where the two deriving unbranched processes
are the connection to the other cells. At first glance, the
cellular reorganization over the two substrates is quite
similar, thus evidencing that the PLGA membrane sys-
tem is comparable to the reference one.
GnRH–secreting neurons were stained for typical
neuronal lineage markers, to further assess also the
ability of the membrane system in addressing and boo-
sting a full cellular differentiation. Images reconstruction
was performed through a confocal microscope analysis
(Figure 1B,C,E,F), which allowed to visualize the co-
localization of distinctive neuronal markers, such as
β-TubIII and NeuN. Representing one of the main neuro-
nal cytoskeletal structural protein, β-TubIII is properly
visible within the soma and along neuronal processes as
indicator of an appropriate cell arrangement within the
new microenvironment. NeuN was also present in the
nuclei and perinuclear cytoplasm. The contemporary
presence of these distinctive markers confirmed that neu-
ronal cells went through the typical morphological
changes of differentiation including axon sprouting and
elongation, demonstrating also the good performance of
the membrane system (Figure 1B). For a complete cellu-
lar analysis overview, a further immunocytochemistry
investigation was carried out to characterize the neuronal
hypothalamic phenotype, through the identification of
the positive expression of specific indicators. To assess
their nature and to confirm that they are GnRH neurons,
hfHypo cells were simultaneously stained for KISS1R, the
receptor for kisspeptin to which hypothalamic cell source
are able to respond, and for the hormone GnRH. As
reported in Figure 1C, confocal images showed the
coexpression of these two markers corroborating that
cultured cells have a GnRH-neuron phenotype. This
evidence is also sustained by the positive immuno-




growth. (A,D) SEM images at
different magnification and
(B–C,E–F) confocal laser
micrographs of neuronal cells at
DIV3 in PLGA membrane
system (A–C) and in PSCD
control system (D–F). Cells were
stained for β-Tub ΙΙΙ (green),
NeuN (red), GPR30 (magenta),
KISS1R (yellow), GnRH (green),
ER β (red), and nuclei (blue).
Scale bar in Confocal images
is 20 μm
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(Figure 1B) and GPR30 (Figure 1C). Both receptors are
extensively visible being typically expressed by this pecu-
liar family of neurons.
As expected the PSCD, being the extensively used ref-
erence system in cell culture studies, allowed the acquisi-
tion of a neuronal hypothalamic phenotype thus hfHypo
cells expressed all investigated neuronal markers. In con-
trast, cells on PSCD were not able to express the estro-
genic receptors, especially GPR30, at the same extent of
those displayed on PLGA membrane system, as shown in
Figure 1E, and the expression and distribution of GnRH
(Figure 1F) was not wide as the one observed on PLGA
membranes (Figure 1C). These evidences validated PLGA
membrane system as reliable hypothalamic tissue model
able also to boost the GnRH phenotypic peculiarity.
3.2 | Modeling neuroinflammation in
the PLGA membrane system
Before assessing the neuroprotective effect of daidzein, it
was necessary to set up an efficient disease model, where
a realistic inflammatory neurological response evoked by
a high-fat dietary intake was reproduced.
SFA palmitate was identified to play an important
role as a mediator involved in the inflammation events
that occur in obesity. Therefore, hypothalamic cells were
exposed to different concentrations of palmitate. To iden-
tify the amount of palmitate that produced a 50% reduc-
tion in cell viability, cells were exposed to a
concentration range of the fatty acid comprised between
0 and 600 μM and the effects evaluated at the time point
of 24 and 48 h (Figure 2). After 24 h, cells exposed to the
concentration of 100 μM of palmitate were still viable
(98.6% ± 5%) with a profile quite similar to the control
(100% ± 3.2%). Incubation with higher concentration of
palmitate affected cell viability in a dose-dependent man-
ner. A viability reduction of 52.9% ± 3.3% was observed
for the concentration of 300 μM with further decline
when cells were treated with higher concentration
(400–600 μM). The prolonged exposure for 48 h reveals
palmitate toxic effect already at the lowest concentration
of 100 μM and a viability decrease to 55.2% ± 12%. A
drastic reduction of cell viability to 6.5% ± 4%, at this
time frame, is observed at the concentration of 300 μM,
and this trend is kept constant with the higher concentra-
tion. These results highlighted cell response to palmitate
time exposure, which significantly affected cell survival.
The concentration of 300 μM for 24 h was identified as
the reference one, and used to model in vitro neu-
roinflammation and to assess the neuroprotection medi-
ated by daidzein co-exposure.
3.3 | Daidzein protects GnRH cells
against palmitate-induced cell death and
reverses its inflammatory induced damage
To evaluate whether daidzein alone is toxic and influ-
ences neuronal cell viability, hfHypo cells were treated
with various concentrations of daidzein (0–20 μM) for
24 h. As shown in Figure 2B, cells maintained high via-
bility levels demonstrating that daidzein is not toxic for
neuronal cells.
The first screening of daidzein neuroprotective effects
included GnRH neurons morphological observation and
their viability assessments, comparing cell response to
different treatments: basal condition with culture media,
FIGURE 2 Viability of hfHypo GnRH neurons in the PLGA
membrane system. (A) Dose-dependent toxic effects of palmitate on
GnRH neuronal cells. Cell viability after 24 and 48 h of treatment
with different concentrations of palmitate. The values expressed as
average ± SD are the means of five experiments and data
statistically significant were evaluated according to ANOVA
followed Bonferroni t-test (p < 0.05). * versus palmitate
200–600 μM; ǂ versus palmitate 300–600 μM; § versus palmitate
400–600 μM; # versus palmitate 600 μM; † versus palmitate
100–600 μM. (B) Cell viability after 24 h of treatment with various
concentrations of daidzein
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exposure to 300 μM palmitate, cells co-treatment of pal-
mitate (300 μM) and daidzein at different concentration
(0.1–1–10 μM).
SEM images reported in Figure 3A display that
hfHypo cells kept in basal condition (I) adhered to the
membrane and maintained their typical morphology; the
induced damage, by exposing cells to 300 μM palmitate
(II), caused cell loss and the few cells still adhered over
the membrane surface exhibited a shrunken morphology
with no projection and therefore a compromised neuro-
nal cells communication. A reversed situation was visible
when cells underwent to a co-treatment with the fatty
acid and the daidzein (III-IV). Indeed, the acute palmi-
tate treatment appeared totally neutralized by the simul-
taneous exposure to daidzein as demonstrated by the
wide membrane surface area covered by the cells while
keeping a proper morphology of healthy cells. The same
trend was observed in terms of cell viability (Figure 3B)
with the graph that clearly shows an increasing cell sur-
vival as increases the concentration of daidzein. When
the phytoestrogen is used at the concentration of 1 and
10 μM the percentage of viable cells was 89% ± 7% and
101% ±6%, respectively, which were significantly higher
than that obtained in cells insulted with palmitate (58%
± 5%). At the concentration of 10 μM, the viability per-
centage was totally restored with value equal to the con-
trol (100% ± 1%), indicating a full protection offered by
the daidzein.
The obesity associated inflammation process, evoked
in the GnRH cells through palmitate exposition and the
cellular counteracting response, activated by the daidzein
treatment, was investigated by quantifying the release of
IL-6 and IL-10, reported in the graph in Figure 4A,B,
respectively. Neuropathological changes are often associ-
ated with the increased IL-6 expression in brain, since
this cytokine plays a pivotal role in the inflammatory
response. Figure 4A depicts IL-6 release and as expected
the palmitate treated cells delivered the highest amount
of the pro-inflammatory cytokine (274 ± 26 pg/106cell) as
a sign of the ongoing neuroinflammation process. The
IL-6 production is gradually reduced when the palmitate
inflammatory stimulus is accompanied by the co-
treatment with daidzein. The graph highlights a progres-
sive IL-6 reduction as the concentration of daidzein
increases; the inhibition of IL-6 production is quite signif-
icant (p < 0.05) at the daidzein treatment of 10 μM as
demonstrated by the reduction of IL-6 secretion at a
value of 51.9 ± 11.3 pg/106cell, which is similar to that of
the untreated cells (22.2 ± 4.3 pg/106cell). To further
asses the daidzein anti-inflammatory properties, the IL-
10 secretion was also analyzed. The anti-inflammatory
cytokine IL-10 is responsible for balancing the immune
response in the brain and therefore produced as a defense
reaction to an inflammatory mediator. The ability of
daidzein to reverse neuroinflammation was supported by
the evidence in graph 4B in which the only palmitate
treatment induces a peak of IL-10 (148.5 ± 23 pg/106cell),
but its production is consistently attenuated by daidzein
co-treatment in a concentration dependent manner.
The high IL-6/IL-10 ratio measured in the palmitate-
treated cells (1.87 ± 0.34) decreased as the concentration
FIGURE 3 Daidzein protected GnRH cells against palmitate-
induced cell death. (A) Representative images depicting the
morphology of neuronal cells after 24 h of treatment with Palmitate
(300 μM) and Daidzein at different concentrations; Control cells
without any treatment (I); Palmitate (300 μM) treatment (II); co-
treatment with: palmitate and daidzein 1 μM (III), palmitate and
daidzein 10 μM (IV). (B) Viability of GnRH cells after treatment
with of Palmitate (300 μM) and Daidzein at different
concentrations (0.1–1–10 μM) for 24 h. The values are presented as
percentages of control (no palmitate treatment). Data are mean
± SEM from three independent experiments and data statistically
significant were evaluated according to ANOVA followed
Bonferroni t-test (p < 0.05): * versus other treatments; ǂ versus
palmitate 300 μM and Palmitate+ daidzein 0.1 μM
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of daidzein increases, reaching value equal to the control
(0.69 ± 0.47) when cells were treated with daidzein
10 μM (0.63 ± 0.17) (Table 2). These findings indicate
that the overall inflammation process was silenced in
response to the daidzein treatment.
3.4 | Daidzein neuroprotection is
mediated by its antioxidant activity and
anti-apoptotic effects
We explored if the neuroprotection, offered by daidzein
to palmitate insulted cells, is evoked by its antioxidant
effect. Therefore, to disclose this mechanism we
proceeded to seek the ability of daidzein in preventing
intracellular ROS accumulation. To this purpose, the
H2DCFDA probe was used to highlight the redox balance
maintenance through daidzein activity. As shown in
Figure 5A palmitate treatment led to a massive produc-
tion of ROS as qualitatively evidenced by the bright green
fluorescence compared with the control. Quantitative
analysis of the green fluorescence emission, whose inten-
sity is directly linked to the ROS production and accumu-
lation, showed that daidzein co-treatment significantly
reduced ROS production in a dose-dependent manner
(Figure 5B). The stronger intracellular antioxidant activ-
ity was obtained at the daidzein concentration of 1 and
10 μM, quantifying a ROS intracellular in the same physi-
ological range of normal cell metabolism.
To further characterize daidzein neuroprotective
properties, its action in preventing the apoptotic cas-
cade was also analyzed. To fulfill this task as first step
was investigated the phytoestrogen potential to avoid
mitochondrial dysfunction. Since mitochondria are
inherently involved in the apoptotic process of cells,
the JC-1 dye was used to monitor mitochondrial per-
meability; indeed, damaged cells undergo to a progres-
sive pore opening with the consequent loss of the
mitochondrial permeability potential (MMP), which is
an intracellular event that occurs during apoptosis. The
JC-1 staining was evaluated in GnRH neuronal cells
kept in different culture conditions in order to assess if
daidzein could protect cells from the palmitate-induced
mitochondrial damage. As shown in Figure 6A when
cells are treated only with palmitate (II) and co-treated
with daidzein 0.1 μM (III) the green fluorescence signal
increased, compared with the control and to the other
samples co-treated with other concentrations of daid-
zein. The increase of the green fluorescence emission
FIGURE 4 Anti-inflammatory role of Daidzein. Daidzein
suppressed palmitate-induced cytokine secretion from GnRH
neurons: IL-6 (A) and IL-10 (B) production. The values expressed as
average ± SD are the means of three experiments and data
statistically significant were evaluated according to ANOVA
followed Bonferroni t-test (p < 0.05). * versus other treatments;
ǂ versus control, palmitate + daidzein 1 μM, palmitate + daidzein
10 μM; † versus control and palmitate + daidzein 10 μM; § versus
control
TABLE 2 IL-6, IL-10, and IL-6/IL-10
ratio
Treatment IL-6 [pg/106cell] IL-10 [pg/106cell] IL-6/IL-10 ratio
Control 22.2 ± 4.3 29.2 ± 18 0.69 ± 0.47
PA 274 ± 26 148.5 ± 23 1.87 ± 0.34
PA+ DZ 0.1 μM 212.6 ± 14.8 121.9 ± 22 1.79 ± 0.39
PA+ DZ 1 μM 97.6 ± 15.4 95.4 ± 21 1.02 ± 0.28
PA+ DZ 10 μM 51.9 ± 11.3 68.9 ± 23 0.63 ± 0.17
Note: Data are presented as mean ± SD.
Abbreviations: DZ daidzein; PA, palmitate.
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indicates mitochondrial damage on the basis of the
JC-1 dye mechanism: it enters the cells from the cyto-
sol to the mitochondria and forms aggregates which
emit a red fluorescence while in apoptotic cells, due to
mitochondrial membrane leakage, JC-1 aggregates go
into the cytosol in monomeric form which emits green
fluorescence. The red fluorescence signal increased by
increasing daidzein concentration as visible in the rep-
resentative confocal images (Figure 6IV–V) proving
that the investigated molecule prevented the mitochon-
dria damage. Quantification of the fluorescence inten-
sity ratio between red/green channels (Figure 6B),
resulting from the proportion healthy/damaged mito-
chondria, reveals how palmitate totally disrupts the
mitochondrial membrane integrity and decreases the
MMP. The ratio between red/green fluorescence signal
increases as an effect of the diadzein exposure, with a
rescue activity more evident at the daizein higher con-
centration. Daidzein prevented MMP collapse exerting
a decisive neuroprotection, especially at the concentra-
tion of 10 μM the palmitate side effects are totally
counterbalanced. Next, we investigated a more specific
aspect of apoptotic process through the immuno-
staining for apoptotic markers by localizing and quanti-
fying the presence of positive cell for Caspase 3 and p-
JNK (Figure 6C). After palmitate treatment 38% ± 13%
and 18% ± 3% of the cells are positive for Caspase
3 and p-JNK, respectively, acting as pro-apoptotic cell
death inducers. In line with the previous evidence, the
co-treatment with daidzein reversed the trend and
although cells were still under the effect of 300 μM pal-
mitate, the synergistic treatment with daidzein
inhibited the palmitate neuro-toxic effects and the
related cells death. Indeed, the number of cells positive
for the two markers significantly decreased, obtaining
at the daidzein highest concentration (10 μM) values of
3% ± 1% and 2% ± 0.7%, for caspase 3 and p-JNK,
respectively, which correspond to the same positive cell
count observed in the control. Disclosing the anti-
apoptotic effects of daidzein was highlighted another
action through which the phytoestrogen exerts
neuroprotection.
FIGURE 5 Anti-oxidant effect of Daidzein. Daidzein inhibited palmitate-induced ROS generation in neuronal cells. (A) Confocal laser
micrographs displaying DCF fluorescence signal in hypothalamic GnRH neurons in basal condition (Control) (I), after palmitate treatment
(300 μM) (II) and after co-treatment with palmitate and daidzein 0.1 (III), 1 (IV) and 10 μM (V). Scale bar: 20 μm. (B) Quantitative analysis
of DCF fluorescence intensity produced in neuronal cells incubated with various concentrations of daidzein and palmitate. The values
expressed as average ± SD are the means of five experiments and data statistically significant were evaluated according to ANOVA followed
Bonferroni t-test (p < 0.05): * versus other treatments; ǂ versus control, palmitate + daidzein 1 μM, palmitate + daidzein 10 μM
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3.5 | Daidzein prevents the palmitate-
induced hfHypo cell dysfunction
As previously described, in standard culture conditions
hfHypo cells widely express markers of the neuronal line-
age, such as β-Tub III and NeuN, as a proof of a proper
degree of differentiation. The GnRH phenotype is also
confirmed by the expression and cellular distribution of
the two specific markers GnRH and KISS1R and by the
positive staining for the estrogenic receptors ERβ and
GPR30 (Figure 7A). The capacity of daidzein to provide
neuroprotection was also investigated by assessing its
mediated effect to preserve the cellular structural integ-
rity under the palmitate inflammatory stimulus. Palmi-
tate toxicity induced a consistent reduction in cell
number and the complete disruption of the normal struc-
ture organization with a drastic reduction in the expres-
sion of the neuronal marker β-Tub III and NeuN
(Figure 7A). In damaged hfHypo cells, the GnRH pheno-
type markers, GnRH and KISS1R are weakly expressed.
The estrogenic receptors ERβ and GPR30 are also visible
only in a small fraction of cells; thus, palmitate evoked its
neurotoxicity through a massive neuronal dedifferentia-
tion and impacting the functional integrity of the GnRH
secreting cells. A complete protection was offered to the
cells by the co-treatment with daidzein 10 μM; the pres-
ence of the phytoestrogen totally compensated the palmi-
tate damage. Confocal pictures reveal healthy cells
expressing NeuN and with a uniform distribution of the
β-Tub III along the unipolar neurite elongation. GnRH
peptide, KISS1R and the estrogenic receptors are broadly
FIGURE 6 Anti-apoptotic effect of daidzein. (A) Daidzein
protected GnRH neurons against palmitate-induced mitochondrial
membrane depolarization. Representative confocal images of
neurons displaying JC1 monomers (green) and aggregates (red) in
basal condition (Control) (I), after palmitate treatment (II) and
after co-treatment with palmitate (300 μM) and daidzein 0.1 (III),
1 (IV), and 10 μM (V). (B) Quantitative analysis of the fluorescence
intensity ratio between JC-1 red and green. The values expressed as
average ± SD are the means of five experiments and data
statistically significant were evaluated according to ANOVA
followed Bonferroni t-test (p < 0.05): * versus other treatments;
ǂ versus palmitate and palmitate + daidzein 0.1 μM treatments.
(C) Daidzein inhibited palmitate-induced apoptotic markers
activation. Quantitative analysis of apoptotic markers Caspase-3
(green bar) and p-JNK (red bar). The values expressed as average
± SD are the means of five experiments and data statistically
significant were evaluated according to ANOVA followed
Bonferroni t-test (p < .05): * versus other treatments; ǂ versus
control, palmitate + daidzein 1 and 10 μM
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expressed evidencing that daidzein prevented palmitate
toxicity protecting cells from losing the peculiar pheno-
type markers. The profile expression patterns for each of
the above-mentioned markers was also quantified and
expressed as the percentage of positive cells over the total
number of cells within the investigated image field
(Figure 7B). After palmitate treatment, the percentage of
cells positive to the neuronal markers β-Tub III and
NeuN, is of 80% ± 6% and 53% ± 9%, respectively, which
are values significantly lower compared with the control.
The number of cells expressing the neuronal lineage pro-
teins increases to 97% ± 3% for β-Tub III and to 88%
± 9% for NeuN when the fatty acid is administered
together with daidzein. This trend is kept constant and
even emphasized for the other markers, where the per-
centage fluctuations of positive cells are more evident. In
FIGURE 7 Daidzein protected GnRH neurons against palmitate-induced cell damage. (A) Confocal laser micrographs of neuronal cells
in PLGA membrane system after different culture conditions: cells without any treatment (Control), Palmitate treatment (Palmitate), and co-
treatment with palmitate and daidzein 10 μM (PA+ DZ). Distribution pattern profile of neuronal markers β-Tub ΙΙΙ (green), and NeuN (red),
GnRH phenotype markers KISS1R (yellow) and GnRH (green), estrogenic receptors ER β (red) and GPR30 (magenta). Nuclei are
counterstained with DAPI (blue). Scale bar: 20 μm. (B) Quantitative analysis of positive cells for each marker. Results are expressed as
percentage of positive cells over total and are reported as average ± SD of the means of five experiments. Data statistically significant were
evaluated according to ANOVA followed Bonferroni t-test (p < 0.05): * versus palmitate treatment
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Figure 7B is clearly visible a drastic downregulation of
cells expressing GnRH (20% ± 6%), KISS1R (22% ± 7%),
ERβ (18% ± 7%), and GPR30 (25% ± 4%) in response to
palmitate insult. In presence of daidzein the percentage
of hfHypo positive cells for these specific proteins signifi-
cantly increases to values of 92% ± 2%, 72% ± 6%, 81%
± 7%, and 84% ± 6%, respectively, in the same range of
the control. Daidzein suppresses the induced palmitate
cell disfunctions, and the inhibitory palmitate effect over
the GnRH phenotype markers and estrogenic receptors
expression is not detectable anymore. Thanks to the
daidzein-mediated neuroprotection the markers expres-
sions remain within a physiological range as a proof of
an appropriate cell functionality.
4 | DISCUSSION
Overnutrition-induced hypothalamic inflammation due
to high-fatty acid diet has become a serious public
health problem because it is associated with severe con-
sequences, including obesity, diabetes, cardiovascular
and neurodegenerative diseases. Thus, many efforts are
directed to identify the compounds or molecules that
can inhibit or reduce the activation of inflammatory
signaling in hypothalamic neurons in order to prevent
or treat obesity and related diseases. The challenge is to
stop the progressive neurodegeneration by inducing
neuroprotection.
The present study provided novel insights on the anti-
neuroinflammatory effects of phytoestrogen daidzein,
potentially relevant to the understanding of the neuro-
protective role of this compound in modulating the
inflammatory processes implicated in the evolution of
several chronic diseases.
Innovative investigational insights on new and effec-
tive therapeutics to treat neurological disorders, and cor-
related pathological events, require the setting up of a
reliable in vitro platform in which the in vivo structure
complexity is recapitulated and maintained.
The in vitro reconstruction of GnRH hypothalamic
tissue-specific microenvironment, created in this work by
using PLGA membrane system, served as model system
to test daidzein's ability to stop and reverse the imbal-
anced neuroinflammatory responses caused by high
fat diet.
PLGA membranes, thanks to their morphological,
mechanical and physico-chemical properties, enable
adhesion, growth and structural and functional neuronal
differentiation of the hfHypo-GnRH neurons, by provid-
ing a microenvironment well-controlled at molecular
level.
In line with a previous study that reports fetal hypo-
thalamus as a rich source of GnRH neurons,23 hfHypo
cells retain their GnRH phenotype in vitro within the
PLGA membrane system. Indeed, they displayed a unipo-
lar or bipolar morphology with long processes to connect
each other. Immunohistochemical data corroborated the
GnRH neuronal phenotype of hfHypo cells, which,
besides markers of the neuronal lineage, such as β-Tub
III and NeuN, also abundantly express GnRH peptide
and the functional kisspeptin receptor, KISS1R, as well as
the estrogenic receptor ERβ, and the transmembrane
estrogen receptor, GPR30, which has been recently impli-
cated in rapid action of estrogen in GnRH neurons.27
The neuronal biohybrid membrane system developed
in this work, consisting of the hfHypo-GnRH neurons in
culture on the PLGA membrane, reproduces the morpho-
functional characteristics of neuronal tissue, and repre-
sents, therefore, a valid model-system of hypothalamic
tissue. The possibility to set up a realistic biomimetic
platform allows to use this system for a breakthrough
investigation of the pathogenic mechanisms at the basis
of the fatty acids/diet neuroinflammation, and also for
the screening of bio-molecules to evaluate their pharma-
cological potential. With this aim, the PLGA membrane
hypothalamic tissue model was used to induce neu-
roinflammation associated with obesity, in order to inves-
tigate the potential anti-neuroinflammatory effect of
phytoestrogen daidzein.
To mimic the inflammatory process associated with
obesity, cultured cells in the PLGA membrane system
were treated with palmitate, a SFA widely present in the
diet, whose excessive intake may induce a hypothalamic
inflammatory state, as demonstrated by several studies in
the literature and confirmed by the present work. The
toxic effect of palmitate involves an increase of pro-
inflammatory cytokines, elevated oxidative stress, and
can result in the death of neuronal cells by apoptosis via
a JNK-dependent pathway.3,25
We have demonstrated, for the first time in primary
cultures of hypothalamic GnRH neurons of human ori-
gin, that the proinflammatory events induced by palmi-
tate treatments have involved the increase of
inflammatory cytokines, reduction of cell viability,
changes in morphology, oxidative stress, and cell death
by apoptosis. Moreover, palmitate action also implicates
the reduction of specific cellular functions by inhibition
of the expression of neuronal markers as well as the
GnRH peptide, kisspeptin receptor (KISS1R) and estro-
genic receptors (ERβ and GPR30). Then, we evaluated
whether daidzein may modulate the deleterious effects
triggered by palmitate administration and related to
obesity-induced neuroinflammation in primary cultures
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of human GnRH neurons by using the developed neural
membrane system that mimics the in vivo conditions. In
particular, the study characterized the effects of daidzein
on palmitate-treated GnRH neurons, with the aim to
evaluate the potential capabilities of this phitoestrogen to
maintain normal cellular phenotype and protect from
oxidative damage, apoptosis, and the deleterious effects
of palmitate-induced inflammation on GnRH neuronal
functions.
The morphology of neuronal cells reflects their struc-
tural and functional integrity, and therefore represents
an index of neuronal growth, viability, and differentia-
tion. We observed how palmitate treatment induced a
significant decrease of the number of cells and morpho-
logical changes of GnRH neurons that assumed a round
shape of the cellular body with high neurite loss, which
is one of the hallmarks of neuronal injury and neu-
rodegeneration. It is evident, therefore, that the palmitate
caused a cellular damage capable of modifying the mor-
phological characteristics typical of such kind of neurons,
which are indispensable to accomplish the normal physi-
ological cellular functions.
Daidzein restored the morphological characteristics
observed in the control cells, consisting of untreated cells,
and furthermore, induced an increase in cell viability in a
concentration-dependent manner highlighting the neuro-
protective action of daidzein against the toxicity induced
by palmitate. These findings are consistent with previous
studies that showed that the administration of daidzein
caused increased survival of cortical neurons exposed to
oxygen and glucose deprivation,12 significantly promoted
the vitality and proliferation of hippocampal neurons and
stimulate the neuritogenesis process.28
To elucidate the anti-inflammatory mechanism
induced by daidzein, further investigations were carried
out focusing on the involvement of cytokines production,
such as IL-6 and IL-10 that have emerged as key regula-
tors of neuroinflammation. IL-6 is classified as a pro-
inflammatory cytokine that may have an anti-
inflammatory effect negatively regulating the inflamma-
tion of acute phase response. In models of brain injury,
infection, LPS injection, or diet-induced obesity, IL-6 is
upregulated and modulates inflammation, apoptosis, and
oxidative stress. Alternatively, IL-6 is also involved in
dampening of the immune responses to promote recovery
and healing.24
IL-10 is an essential anti-inflammatory cytokine that
is released from several cell types, after immune chal-
lenge and brain injury, and is responsible for tissue remo-
deling and restoration of homeostatic conditions. Barabas
et al., provided the first evidence that IL-10 directly regu-
lates the functions of GnRH neurons.29
Daidzein suppressed palmitate-mediated production
of the investigated inflammatory cytokines demonstrat-
ing that daidzein had also direct anti-inflammatory prop-
erties in addition to its function to prevent cell death.
These results are in agreement with a previous report, in
which daidzein treatment significantly attenuated the
inflammatory IL-6 expression in an in vitro model of adi-
pose inflammation,13 suppressed IL-10 secretion from
LPS treated human dendritic cells,30 and attenuated
cisplatin-induced inflammatory cytokines interleukin
10 (IL-10) in mice with renal damage.9 To the best of our
knowledge, this is the first study showing that daidzein
inhibits pro-inflammatory cytokines in human GnRH
neurons. Additionally, Ropelle et al., report that recombi-
nant IL-6 requires IL-10 expression to suppress hyperpha-
gia in the hypothalamus of obese animals.31 IL-6 induces
an anti-inflammatory environment by inducing the pro-
duction of IL-10. Therefore, we can hypothesize that
palmitate-induced increase of IL-10 levels may be related
to the IL-6 anti-inflammatory response, which involves
the increase of IL-10 expression in the hypothalamus,
accordingly with Ropelle.31 In addition, to evaluate the
balance between pro- and anti-inflammatory cytokines
which controls various physiological processes and the
imbalance of which is related to several human diseases,
the decrease of IL-6/IL-10 ratio obtained administering
daidzein in palmitate-treated cells demonstrates its role
in inhibiting the inflammation process.
It is noteworthy that cytokines had an effect on gene
expression in GnRH neurons or neuron function, since
GnRH neurons express cytokine receptors.32 Indeed, we
previously demonstrated deleterious effects of TNFα on
KISS1R signaling and GnRH secretion in the same cellu-
lar model.23 In the present work, we found an effect of
palmitate-induced inflammation on cytokines production
and phenotype markers, as well as estrogenic receptors.
In particular, the palmitate inflammation induced an
increase of IL-6 and IL-10 and a decrease of KISS1R,
GnRH, ERβ, and GPR30 expression highlighting a rela-
tionship between cytokines and markers of phenotype
and estrogenic receptors, in accordance with previous
studies.23,32 This effect was completely reversed by daid-
zein treatment that plays a neuroprotective role in
impaired hfHypo cells.
Particular attention was paid to the ability of phytoes-
trogen daidzein to counteract the negative and toxic
effects caused by palmitate on phenotype and function of
hypothalamic GnRH neurons. Palmitate treatment cau-
sed a very low expression and localization of typical neu-
ronal lineage markers such as β-Tub III and NeuN that
leads to the loss of their well-defined neuronal morphol-
ogy. The SFA exposure determined a specific
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inflammatory intracellular signaling characterized by
reduced GnRH and KISS1R expression.
This direct inhibitory effect on KISS1R expression
observed in our study is consistent with recent reports
that demonstrated the association of impairment caused
by inflammatory injury with a downregulation of KISS1R
in GnRH neuron.23,33 Our finding supports the idea that
the deleterious effects of inflammation on GnRH neurons
function, activated by palmitate, are exerted through the
decrease of GnRH and KISS1R expression. In line with
our expectations, the administration of palmitate was
able to decrease not only the number of neuronal cells,
but it also negatively affected the phenotype and function
of hypothalamic GnRH-secreting neurons.
Daidzein restored the neuronal morphology and the
correct GnRH phenotype. The intense distribution of
β-Tub III and NeuN markers indicated the neuronal phe-
notype of primary culture. Daidzein significantly
inhibited the adverse effects of palmitate on GnRH
expression, accordingly with in vivo data that showed
how the administration of daidzein determined a marked
up-regulation of the levels of mRNA of GnRH in the
hypothalamus.34 Accordingly, daidzein-treated hfHypo
cells exhibited the predominant hypothalamic GnRH/
KISS1R phenotype, as demonstrated by
immuncytochemical analysis. The ability of daidzein in
restoring both GnRH and KISS1R expression are
extremely relevant by a functional point of view, since
kisspeptin is the main physiological regulator of the
hypothalamic GnRH system, which governs the repro-
ductive function.
The protective actions of phytoestrogens are mediated
by the activation of intracellular nuclear receptor family,
ERα and ERβ, which are located in the cytoplasm or on
the nuclear membrane. Recent studies have suggested
that the transmembrane G protein-coupled receptor
30 (GPR30) may be involved in estrogen anti-
inflammatory action. Using human fetal primary cholin-
ergic neurons, it has been recently demonstrated that
GPR30 is specifically implicated in mediating neuro-
protective effects of estrogens under inflammatory stimu-
lus.27 Other investigations report that daidzein in the
presence of glutamate, used to induce toxicity in primary
hippocampal neurons, decreased the level of ERβ without
significant changing of the GPR30 protein level.35 Our
results showed, for the first time that daidzein is able to
increase the expression levels of both ERβ and GPR30 in
the presence of palmitate-induced inflammatory stimulus
in hypothalamic GnRH neurons, thus suggesting that
these receptors could be involved in the mechanism of
action of daidzein in determining neuroprotection
against neuroinflammation of obese individuals. In sup-
port of this hypothesis, scientific data showed that
daidzein, thanks to its structural homology with 17β-
estradiol, is able to bind to the classical estrogenic recep-
tor ERβ in hippocampal neurons, stimulating the growth
of their axons36; while more recent data suggest that its
main metabolite equol is able to inhibit neu-
roinflammation induced by LPS in astrocytes by pathway
mediated by the GPR30.37
SFA induce mitochondrial damage and oxidative
stress that are accompanied by excessive production
and/or insufficient removal of ROS. In general,
isoflavones are known to be antioxidant, and, indeed,
daidzein suppressed ROS production in microglia during
LPS-induced neuroinflammation,8 and also in mouse
models of cerebral ischemia reduced oxidative stress cau-
sed by increased activity of the enzyme superoxide dis-
mutase.38 The neuroprotection effect of daidzein could be
due to its chemical structure that allows to play a role of
scavenger of free radicals by hydrogen atom donation,
protecting in this way cells from oxidative damage.
Herein, we have demonstrated that the treatment with
daidzein avoids palmitate-induced ROS production that
is responsible for cell impairment. These results clearly
indicate and thus confirm the antioxidant properties of
such phytoestrogen.
It is known that the neuroinflammation associated
with obesity is characterized also by the apoptotic process
activation. Excessive ROS, induced by palmitate, can lead
to mitochondrial dysfunctions with loss of the mitochon-
drial membrane potential (MMP), which is widely con-
sidered as an early intracellular event of the apoptotic
cascade. Palmitate caused a drastic depolarization of
MMP and the treatment with daidzein had a
concentration-dependent protective effect on mitochon-
dria. Therefore, our results demonstrated that daidzein
can prevent the palmitate-induced collapse of MMP,
suggesting a strong protective effect against palmitate-
induced mitochondrial dysfunction. Thus, daidzein neu-
roprotective action could be related to the recovery of
mitochondrial bioenergetics and functions, and the
capacity to inhibit the apoptotic process triggered by pal-
mitate, suggesting therefore its anti-apoptotic effect.
Several molecular studies provided evidences that
inflammatory responses are mediated by JNK activa-
tion.39 Recently, Tse et al.25 demonstrated that activation
of JNK is required for palmitate-induced inflammation,
specifically, other authors report that SFA palmitate, may
induce neuroinflammation through pathways involving
the activation of JNK and caspase 3.2 Moreover, daidzein
inhibited secretion of pro-inflammatory cytokines in
adipocyte-macrophage co-cultures via multiple pathways
in which JNK activation is involved.13
Within this scenario, we further explored the daid-
zein anti-apoptotic effect by investigating the ability of
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this phytoestrogen in preventing palmitate-induced acti-
vation of JNK and Caspase-3, since they are implicated
in the sequence of events leading to apoptosis. Indeed,
JNK represents the upstream sensor protein, which is
activated following a condition of oxidative stress due
to palmitate treatment, and caspase 3 represents the
downstream apoptotic effector molecule. To have a gen-
eral overview at upstream and downstream of JNK acti-
vation, we have evaluated the capacity of daidzein to
inhibit ROS production, since it acts as potent inducer
of JNK, and one of the antiapoptotic mechanisms is to
remove the ROS to prevent JNK activation.40 JNK is
also involved in other apoptotic signal activation as the
downstream mitochondrial/caspase-9 pathway whose
activity converges on the activation of caspase-3, which
is then a downstream effector of JNK pathway.41
Importantly, the treatment with daidzein blocked JNK
phosphorylation and caspase-3 cleavage and, thus,
prevented the deleterious effects of palmitate by regulat-
ing signaling pathways within neurons and inhibiting
the onset of the apoptotic process. The study also
analyzed the loss of mitochondrial membrane potential
that is considered as an early indicator of apoptosis.
Therefore, we sought for representative events that
occur in the apoptotic cascade, with the final goal to
provide evidence about daidzein's anti-apoptotic effect,
to gain insight into the mechanism underlying the
daidzein-induced neuroprotection.
Overall, our data demonstrated that cell death, mor-
phological changes, interleukins and ROS production, as
well as apoptotic state, and impaired functionality evoked
by palmitate-activated neurons, were significantly
inhibited in a dose-dependent manner by daidzein co-
treatment. The putative mechanism of the neuro-
protetctive effect of daidzein against palmitate-induced
hypothalamic inflammation is summarized in Figure 8.
On the basis of the collected data we can suppose that
daidzein, thanks to its chemical structure, which includes
a phenolic ring, can directly bind to the estrogen recep-
tors and regulate the hypothalamic cellular functions,
coherently with other studies.42 Overall, the present
study highlights the therapeutic potential of daidzein in
FIGURE 8 Anti-neuroinflammatory effect of daidzein in GnRH neurons. Daidzein was able to counteract the detrimental effects of
palmitate by eliciting an increased viability and diminishing ROS and interleukins production. Daidzein displayed anti-apoptotic action by
downregulating mitochondrial dysfunction and p-JNK and caspase-3 activation. Importantly, daidzein upregulated markers of neuronal
linage and GnRH phenotype and also mediated the activation of ERβ and GPR30 receptors in palmitate-treated cells
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the prevention of neuroinflammation caused by high-fat
diets.
5 | CONCLUSIONS
This study provides novel insight into the anti-
neuroinflammatory effects of daidzein on hfHypo cells.
PLGA membrane system enhanced the creation of func-
tional hypothalamic neuronal tissue analogue that was
successfully employed as a valuable tool for testing the
neuroprotective effect of daidzein against high fat diet-
induced inflammation.
The molecular mechanism of daidzein
neuroprotection was mediated through downregulation
of palmitate-induced cell impairment. Specifically, the
phytoestrogen not only inhibited palmitate-induced
neuronal death and pro-inflammatory cytokines secre-
tion, but also protected from neuroinflammatory injury
through downregulation of ROS production, mitochon-
drial dysfunction and p-JNK and caspase-3 activation,
thus demonstrating both antioxidant and anti-
apoptotic action. Furthermore, daidzein was able to
suppress the inhibitory effect of palmitate on the
expression of specific markers of neuronal linage and
GnRH phenotype, suggesting its role in restoring the
correct neuronal morphology and functionality of
hfHypo GnRH cells. In addition, its protective action
was also mediated by the activation of ERβ and GPR30
receptors.
Our data highlight the therapeutic potential of daid-
zein in counteracting neuroinflammation caused by
high-fat diets, and therefore, in the prevention of the
related diseases. Since GnRH neurons play a key role
in controlling the hormonal network crucial for sus-
taining the reproductive function, our findings could
advance the understanding not only of the mechanisms
underlying daidzein neuroprotective effect, but also of
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